Home
>
US Stocks
>
Ziopharm Oncology, Inc.
Ziopharm Oncology, Inc.
ZIOP

Ziopharm Oncology, Inc. (ZIOP)

$1.642.38%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
1.69
Today Low/High
1.59 / 1.69
52 Week Low/High
$1.62 / $5.95
Market Cap
$362.14M

Company Details

Ziopharm Oncology is an immuno-oncology company focused on developing end-to-endcost-effective solutions using its non-viralSleeping Beauty platform for TCR and CAR T-cell therapies and immune-stimulating gene therapy with Controlled interleukin 12 (IL-12). The Sleeping Beauty platform genetically modifies T cells with DNA plasmids to express T-cell receptors (TCRs) to target specific antigens in solid tumors and chimeric antigen receptors (CARs) to target CD19 in blood cancers with the Company's 3rd generation T-cell manufacturing process, rapid personalized manufacture (RPM). The Sleeping Beauty platform is being advanced in collaboration with the National Cancer Institute, The University of Texas MD Anderson Cancer Center and Eden BioCell. The Company also is developing its Controlled IL-12 platform, or Ad-RTS-hIL-12 plus veledimex, as monotherapy and in combination with immune checkpoint inhibitors to treat brain cancer, including in collaboration with Regeneron Pharmaceuticals.
Organisation
Ziopharm Oncology, Inc.
Employees
105
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Ziopharm Oncology, Inc. (ZIOP) share price today?

Can Indians buy Ziopharm Oncology, Inc. (ZIOP) shares?

How can I buy Ziopharm Oncology, Inc. (ZIOP) shares from India?

Can Fractional shares of Ziopharm Oncology, Inc. (ZIOP) be purchased?

What are the documents required to start investing in Ziopharm Oncology, Inc. (ZIOP) stocks?

We are a SEBI registered investement advisor